<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> FR89407-0032 </DOCNO><DOCID>fr.4-07-89.f2.A1031</DOCID><TEXT><ITAG tagnum="69"><ITAG tagnum="41">[Docket No. 89-044] </ITAG><ITAG tagnum="56">U.S. Veterinary Biological Product and Establishment Licenses Issued,Suspended, Revoked, or Terminated </ITAG><ITAG tagnum="10"><T2>AGENCY:</T2> Animal and Plant Health Inspection Service, USDA.</ITAG><ITAG tagnum="10"><T2>ACTION:</T2> Notice. </ITAG><ITAG tagnum="10"><T2>SUMMARY:</T2> The purpose of this notice is to advise the public ofthe issuance, suspension, revocation, or termination of veterinary biologicalproduct and establishment licenses by the Animal and Plant Health InspectionService during the month of February 1989. These actions are taken in accordancewith the regulations issued pursuant to the Virus-Serum-Toxin Act.</ITAG><ITAG tagnum="10"><T2>FOR FURTHER INFORMATION CONTACT:</T2> Joan Montgomery, Program Assistant,Veterinary Biologics Staff, Biotechnology, Biologics, and EnvironmentalProtection, Animal and Plant Health Inspection Service, U.S. Departmentof Agriculture, Room 838, Federal Building, 6505 Belcrest Road, Hyattsville,MD 20782, (301) 436-6332.</ITAG><ITAG tagnum="10"><T2>SUPPLEMENTARY INFORMATION:</T2> The regulations in 9 CFR Part 102,``Licenses For Biological Products,'' require that every person who preparescertain biological products that are subject to the Virus-Serum-Toxin Act(21 U.S.C. 151 <T3>et seq.</T3>) shall hold an unexpired, unsuspended, and unrevoked U.S.Veterinary Biological Product License. The regulations set forth the proceduresfor applying for a license, the criteria for determining whether a licenseshall be issued, and the form of the license. Pursuant to these regulations, the Animal and Plant Health Inspection Service(APHIS) issued the following U.S. Veterinary Biological Product Licensesduring February 1989: <ITAG tagnum="110"><C/> <H1>Product License Code</H1><H1>Date Issued </H1><H1>Product</H1><H1>Establishment</H1><H1>Establishment License No.</H1><ITAG tagnum="1">4570.20<D>02-01-89</D><D>Bovine Rota-Coronavirus Vaccine-Clostridium Perfringens Type C-EscherichiaColi Bacterin-Toxoid, Killed Virus</D><D>SmithKline Beckman Corporation</D><D>189</D></ITAG><ITAG tagnum="1">1631.02<D>02-01-89</D><D>Marek's Disease Vaccine, Live Chicken Herpesvirus</D><D>Tri-Bio Laboratories, Inc. </D><D>275</D></ITAG><ITAG tagnum="1">16G8.00<D>02-01-89</D><D>Marek's Disease Vaccine, Live Chicken and Turkey Herpesvirus</D><D>Tri-Bio Laboratories, Inc. </D><D>275</D></ITAG><ITAG tagnum="1">B665.00<D>02-03-89</D><D>Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona,Killed Culture</D><D>Agrion Corporation</D><D>213</D></ITAG><ITAG tagnum="1">1171.21<D>02-09-89</D><D>Bovine Rhino-tracheitis-Virus Diarrhea-Parain-fluenza Vaccine, ModifiedLive Virus</D><D>Coopers Animal Health, Inc. </D><D>107</D></ITAG><ITAG tagnum="1">G425.00<D>02-09-89</D><D>Clostridium-Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C andamp;D Moraxella Bovis Bacterin-Toxoid, For Further Manufacture</D><D>Boehringer, Ingelheim Animal Health, Inc. </D><D>124</D></ITAG><ITAG tagnum="1">12D5.00<D>02-10-89</D><D>Bursal Disease-Reovirus Vaccine, Standard and Variant, Killed Virus</D><D>Intervet America Inc.</D><D>286</D></ITAG><ITAG tagnum="1">12M5.00<D>02-10-89</D><D>Bursal Disease-Newcastle-Bronchitis-Reovirus Vaccine, Standard and Variant,Mass. Type, Killed Virus</D><D>Intervet America Inc.</D><D>286</D></ITAG><ITAG tagnum="1">2051.00<D>02-10-89</D><D>Autogenous Bacterin </D><D>Biomune, Incorporated</D><D>368</D></ITAG><ITAG tagnum="1">7055.00<D>02-13-89</D><D>Bordetella Bronchispetica-Erysipelothrix Rhusiopathiae-Pasteurella MultocidaBacterin-Toxoid </D><D>Schering Corporation </D><D>165-A</D></ITAG><ITAG tagnum="1">B070.00<D>02-15-89</D><D>Mycoplasma Gallisepticum Antigen, For Further Manufacture</D><D>Rhone Merieux, Inc.</D><D>298</D></ITAG><ITAG tagnum="1">1205.21<D>02-16-89</D><D>Bovine Virus Diarrhea Vaccine, Killed Virus </D><D>SmithKline Beckman Corporation </D><D>189</D></ITAG><ITAG tagnum="1">1561.20<D>02-16-89</D><D>Feline Panleukopenia Vaccine, Modified Live Virus</D><D>Salsbury Laboratories, Inc. </D><D>195</D></ITAG><ITAG tagnum="1">1891.R1<D>02-21-89</D><D>Pseudorabies Vaccine, Modified Live Virus</D><D>Fermenta Animal Health Co. </D><D>272</D></ITAG><ITAG tagnum="1">48C5.20<D>02-21-89</D><D>Parvovirus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-PomonaBacterin, Killed Virus</D><D>Grand Laboratories Inc. </D><D>303</D></ITAG><ITAG tagnum="1">2859.00<D>02-23-89</D><D>Trichomonas Foetus Vaccine, Killed Protozoa </D><D>American Home Products Corporation </D><D>112</D></ITAG><ITAG tagnum="1">2863.02<D>02-27-89</D><D>Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-PomonaBacterin </D><D>SmithKline Beckman Corporation </D><D>189</D></ITAG><ITAG tagnum="1">1015.10<D>02-27-89</D><D>Autogenous Vaccine, Killed Virus</D><D>Intervet America Inc. </D><D>286</D></ITAG><ITAG tagnum="1">2825.00<D>02-27-89</D><D>Salmonella Typhimurium Bacterin </D><D>Grand Laboratories Inc. </D><D>303</D></ITAG></ITAG>The regulations in 9 CFR Part 102 also require that each person who preparesbiological products that are subject to the Virus-Serum-Toxin Act (21 U.S.C.151 <T3>et seq.</T3>) shall hold a U.S. Veterinary Biological EstablishmentLicense. The regulations set forth the procedures for applying for a license,the criteria for determining whether a license shall be issued, and theform of the license. No U.S. Veterinary Biological Establishment Licenseswere issued during February 1989. The regulations in 9 CFR Parts 102 and 105 also contain provisions concerningthe suspension, revocation, and termination of U.S. Veterinary BiologicalProduct Licenses and U.S. Veterinary Biological Establishment Licenses.Pursuant to these regulations, APHIS terminated the following U.S. VeterinaryBiological Product License during February 1989: <ITAG tagnum="110"><C>5,L2,tp0,s10,10,r15,r15,10 </C> <H1>Product License Code </H1><H1>Date terminated </H1><H1>Product</H1><H1>Establishment </H1><H1>Establishment License No. </H1> <ITAG tagnum="1">1475.00<D>02-23-89</D><D>Encephalomyelitis Vaccine, Eastern and Western, Killed Virus </D><D>Coopers Animal Health, Inc. </D><D>107</D></ITAG></ITAG><ITAG tagnum="21">Done at Washington, DC, this 31st day of March 1989. </ITAG><ITAG tagnum="6">Larry B. Slagle, </ITAG><ITAG tagnum="4">Acting Administrator, Animal and Plant Health Inspection Service. </ITAG><ITAG tagnum="40">[FR Doc. 89-8203 Filed 4-6-89; 8:45 am]</ITAG><ITAG tagnum="68">BILLING CODE 3460-34-M </ITAG></ITAG></ITAG></TEXT></DOC>